Hereditary Hemorrhagic Telangiectasia (HHT) is a genetic disorder characterized by abnormal blood vessel formation. The ICD-10 code for HHT is Q27.3. In the previous coding system, ICD-9, the code for HHT was 448.0. These codes are used for medical billing and documentation purposes to accurately identify and classify the condition for healthcare providers.
Hereditary Hemorrhagic Telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome, is a rare genetic disorder that affects the blood vessels. It is characterized by the development of abnormal blood vessels, known as telangiectasias, which are prone to bleeding and can cause various complications.
The International Classification of Diseases, 10th Revision (ICD-10), provides a specific code for Hereditary Hemorrhagic Telangiectasia. The ICD-10 code for this condition is Q27.3. This alphanumeric code is part of the Q00-Q99 chapter of the ICD-10, which covers congenital malformations, deformations, and chromosomal abnormalities.
In contrast, the ICD-9 code for Hereditary Hemorrhagic Telangiectasia is 448.0. The ICD-9-CM (Clinical Modification) is the ninth revision of the ICD, and it was used prior to the implementation of ICD-10.
It is important to note that the ICD-10 code Q27.3 and the ICD-9 code 448.0 are specific to Hereditary Hemorrhagic Telangiectasia and should be used when documenting and reporting this condition. These codes assist healthcare professionals in accurately identifying and coding diseases, facilitating appropriate treatment, research, and statistical analysis.
In summary, the ICD-10 code for Hereditary Hemorrhagic Telangiectasia is Q27.3, while the ICD-9 code is 448.0. These codes help classify and identify this rare genetic disorder, supporting the healthcare community in providing appropriate care and maintaining accurate medical records.